Skip to content
healthcare.dev

Cholestyramine for Oral Suspension

NDC 62135-008, Cholestyramine for Oral Suspension, powder, from Chartwell RX, LLC.

Product NDC
62135-008
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
POWDER
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074561
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHOLESTYRAMINE4 g/9g

Pharmacologic classes

Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]

Package NDCNDC-11Package
62135-008-5662135000856378 g in 1 CAN (62135-008-56)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/80db0042-0c05-4509-8a6b-fa9f4783629a
  • NADAC price for package 62135000856

    GET /v1/drugs/nadac/62135000856

Use it

Look up 62135-008 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.